Gulosibacter bifidus Details: NCBI 272239, high G+C gram-positive [species]

| 'Pseudoclavibacter bifida'| CCUG 50209| CIP 108567| DSM 17450| IAM 14848| JCM 12920| NBRC 103089| Pseudoclavibacter bifida| Zimmermannella bifida| Zimmermannella bifida Lin et al. 2004

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Gulosibacter bifidus

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 5.43 0 0 10 15100 0 3700 464.5 69 1650.8 0 411 0 %ile 100 %ile
biomesight 3.31 0 0 10 15100 0 3762 397.5 70 1716.6 0 330 0 %ile 100 %ile
thorne 3.45 0 1 1 1 1 1 0 %ile 99 %ile
thryve 0.9 12 890 0 672 140.5 35 271.4 12 890 8.3 %ile 83.3 %ile
ubiome 3.68 21 9340 0 4251 670.3 98 1826.8 0 890 0 %ile 100 %ile

External Reference Ranges for Gulosibacter bifidus

Gulosibacter bifidus (NCBI 272239) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Gulosibacter bifidus
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 3.642 %   0.037 %  0.15 % 108.0 2965
Thryve 0.863 %   0.014 %  0.019 % 12.0 1390
uBiome 3.662 %   0.067 %  0.183 % 29.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.